BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 19259692)

  • 1. Actual management of ductal carcinoma in situ of the breast.
    Maass N; Alkasi O; Bauer M; Jonat W; Souchon R; Meinhold-Heerlein I
    Arch Gynecol Obstet; 2009 Nov; 280(5):699-705. PubMed ID: 19259692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal management of ductal carcinoma in situ of the breast.
    Sakorafas GH; Farley DR
    Surg Oncol; 2003 Dec; 12(4):221-40. PubMed ID: 14998563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ductal carcinoma in situ (DCIS) of the breast: evolving perspectives.
    Sakorafas GH; Tsiotou AG
    Cancer Treat Rev; 2000 Apr; 26(2):103-25. PubMed ID: 10772968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mammographically detected, clinically occult ductal carcinoma in situ treated with breast-conserving surgery and definitive breast irradiation.
    Solin LJ; McCormick B; Recht A; Haffty BG; Taylor ME; Kuske RR; Bornstein BA; McNeese M; Schultz DJ; Fowble BL; Barrett W; Yeh IT; Kurtz JM; Amalric R; Fourquet A
    Cancer J Sci Am; 1996; 2(3):158-65. PubMed ID: 9166516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of ductal carcinoma in situ of the breast: review of recent advances and future prospects.
    Mokbel K
    Int J Fertil Womens Med; 2003; 48(5):217-25. PubMed ID: 14626378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salvage treatment for local recurrence after breast-conserving surgery and radiation as initial treatment for mammographically detected ductal carcinoma in situ of the breast.
    Solin LJ; Fourquet A; Vicini FA; Haffty B; Taylor M; McCormick B; McNeese M; Pierce LJ; Landmann C; Olivotto IA; Borger J; de La Rochefordiere A; Schultz DJ
    Cancer; 2001 Mar; 91(6):1090-7. PubMed ID: 11267953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of treatment for ductal carcinoma in situ of the breast in Louisiana, 1988-1999.
    Wu X; Chen VW; Ruiz B; Andrews PA; Hsieh MC; Schmidt BA; Correa CN; Fontham ET
    J La State Med Soc; 2003; 155(4):206-13. PubMed ID: 14506828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [New therapeutic perspectives in breast ductal carcinoma in situ].
    Ladekarl M; Grau C; Andersen J
    Ugeskr Laeger; 2001 Sep; 163(37):5014-7. PubMed ID: 11573374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is excision alone adequate treatment for low-risk ductal carcinoma-in-situ of the breast?
    Solin LJ
    J Clin Oncol; 2006 Mar; 24(7):1017-9. PubMed ID: 16461780
    [No Abstract]   [Full Text] [Related]  

  • 10. Contemporary treatment of ductal carcinoma in situ of the breast.
    Mokbel K
    Med Sci Monit; 2005 Mar; 11(3):RA86-93. PubMed ID: 15735580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ductal carcinoma in situ of the breast: our experience.
    Ruggiero R; Procaccini E; Sanguinetti A; Cremone C; Gili S; Docimo G; Docimo L; Sparavigna L; Gubitosi A; Parmeggiani D; Avenia N
    G Chir; 2009 Mar; 30(3):121-4. PubMed ID: 19351465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances and current controversies in the management of DCIS of the breast.
    Sakorafas GH; Farley DR; Peros G
    Cancer Treat Rev; 2008 Oct; 34(6):483-97. PubMed ID: 18490111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DEGRO practical guidelines for radiotherapy of breast cancer I: breast-conserving therapy.
    Sautter-Bihl ML; Budach W; Dunst J; Feyer P; Haase W; Harms W; Sedlmayer F; Souchon R; Wenz F; Sauer R; ;
    Strahlenther Onkol; 2007 Dec; 183(12):661-6. PubMed ID: 18040609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of ductal carcinoma in situ after excision: would a prophylactic paradigm be more appropriate?
    Punglia RS; Schnitt SJ; Weeks JC
    J Natl Cancer Inst; 2013 Oct; 105(20):1527-33. PubMed ID: 24068769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853--a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group.
    ; ; Bijker N; Meijnen P; Peterse JL; Bogaerts J; Van Hoorebeeck I; Julien JP; Gennaro M; Rouanet P; Avril A; Fentiman IS; Bartelink H; Rutgers EJ
    J Clin Oncol; 2006 Jul; 24(21):3381-7. PubMed ID: 16801628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Re: Trends in the treatment of ductal carcinoma in situ of the breast.
    Zorbas H; Luxford K; Evans A; Villanueva EV
    J Natl Cancer Inst; 2004 Aug; 96(16):1258; author reply 1259-60. PubMed ID: 15316063
    [No Abstract]   [Full Text] [Related]  

  • 17. Ductal carcinoma in situ: a disease entity that merits more recognition.
    Dereere E; Papadimitriou K; Tjalma W; Altintas S
    Minerva Chir; 2015 Aug; 70(4):231-9. PubMed ID: 25916193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local recurrence after conservative surgery and radiation therapy for ductal carcinoma in situ: Possible importance of family history.
    Hiramatsu H; Bornstein BA; Recht A; Schnitt SJ; Baum JK; Connolly JL; Duda RB; Guidi AJ; Kaelin CM; Silver EB; Harris JR
    Cancer J Sci Am; 1995; 1(1):55-61. PubMed ID: 9166455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001.
    Li CI; Malone KE; Saltzman BS; Daling JR
    Cancer; 2006 May; 106(10):2104-12. PubMed ID: 16604564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [In situ carcinomas of the breast: clinical features and therapeutic strategies].
    Attene F; Scognamillo F; Trignano E; Meloni GB; Rubino C; Trignano M
    Ann Ital Chir; 2006; 77(1):3-10; discussion 10-2. PubMed ID: 16910353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.